About
ArcDia International Oy Ltd is a Finnish biotechnology company based in Turku, established in 2008. The company specializes in developing and manufacturing advanced in-vitro diagnostic (IVD) systems, focusing on rapid and accurate testing for infectious diseases. Its core technology, the ArcDia™ TPX detection method, supports multianalyte point-of-care diagnostics and is backed by over 15 international patents. The flagship product, the mariPOC® platform, is an automated diagnostic system that identifies pathogens and detects inflammation markers and antimicrobial resistance. It addresses various infectious diseases, including respiratory and gastrointestinal infections, and has capabilities for testing COVID-19 and other viruses. ArcDia targets healthcare providers and laboratories, offering decentralized diagnostic solutions to enhance patient management. The company has established international distribution partnerships, including an exclusive agreement with Bruker Corporation for Central Europe. With a team of around 30 professionals from diverse fields, ArcDia also provides research contracts and licensing opportunities for its proprietary technologies.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 1993
-
Annual Revenue $10000000
Location
32 Lemminkaeisenkatu, Turku, Finland, 20520